IHS Chemical Week

World News and Views :: Top of the News

Merck & Co. Buys Back its Riverside Pharmaceutical Intermediates Plant

1:34 AM MDT | August 11, 2010 | Natasha Alperowicz

Merck & Co. says it will buy back its Riverside, PA pharmaceutical ingedients plant from PRWT Services (Philadelphia), a company that acquired the facility from Merck in 2008. Cherokee Pharmaceuticals, a wholly owned subsidiary of PRWT, is the operator of the plant. The company took over the unit at a time when major drug firms were increasingly outsourcing pharmaceutical ingredients manufacturing to save costs. The plant makes intermediate compounds for two antibiotics, Invanz and Primaxin. It also makes Merck's cholesterol drug, MK524, and Avermectin, an...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa